Negative Vaccine Attitudes and Intentions to Vaccinate Against Covid-19 in Relation to Smoking Status: A Population Survey of UK Adults

Sarah E Jackson, Elise Paul, Jamie Brown, Andrew Steptoe, Daisy Fancourt, Sarah E Jackson, Elise Paul, Jamie Brown, Andrew Steptoe, Daisy Fancourt

Abstract

Introduction: We examined differences in negative attitudes toward vaccines in general, and intentions to vaccinate against Covid-19 specifically, by smoking status in a large sample of adults in the UK.

Method: Data were from 29 148 adults participating in the Covid-19 Social Study in September-October 2020. Linear regression analyses examined associations between smoking status (current/former/never) and four types of general negative vaccine attitudes: mistrust of vaccine benefit, worries about unforeseen effects, concerns about commercial profiteering, and preference for natural immunity. Multinomial logistic regression examined associations between smoking status and uncertainty and unwillingness to be vaccinated for Covid-19. Covariates included sociodemographic characteristics and diagnosed health conditions.

Results: Relative to never and former smokers, current smokers reported significantly greater mistrust of vaccine benefit, were more worried about unforeseen future effects, had greater concerns about commercial profiteering, and had a stronger preference for natural immunity (Badjs 0.16-0.36, p < .001). Current smokers were more likely to be uncertain (27.6% vs. 22.7% of never smokers, RRadj 1.43 [95% confidence interval = 1.31-1.56]; vs. 19.3% of former smokers, RRadj 1.55 [1.41-1.73]) or unwilling (21.5% vs. 11.6% of never smokers, RRadj 2.12 [1.91-2.34]; vs. 14.7% of former smokers, RRadj 1.53 [1.37-1.71]) to receive a Covid-19 vaccine.

Conclusions: Current smokers hold more negative attitudes toward vaccines in general, and are more likely to be undecided or unwilling to vaccinate against Covid-19, compared with never and former smokers. With a disproportionately high number of smokers belonging to socially clustered and disadvantaged socioeconomic groups, lower vaccine uptake in this group could also exacerbate health inequalities.

Implications: These results suggest that without intervention, smokers will be less likely than nonsmokers to take up the offer of a Covid-19 vaccine when offered. Targeted policy action may be required to ensure that low uptake of Covid-19 vaccination programs does not compound health inequalities between smokers and nonsmokers.

© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.

References

    1. Shin MD, Shukla S, Chung YH, et al. . COVID-19 vaccine development and a potential nanomaterial path forward. Nat Nanotechnol. 2020;15(8):646–655.
    1. Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol. 2020;20(10):615–632.
    1. World Health Organization. Draft landscape of COVID-19 candidate vaccines. 2020. . Cited November 18, 2020.
    1. Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 9). Qeios. 2020. . Cited November 17, 2020.
    1. Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Addiction. .Cited November 17, 2020.
    1. Samuel H. Smokers “four times less likely” to contract Covid-19, prompting nicotine patch trials on patients. The Telegraph. 2020. . Cited February 2, 2021.
    1. Blanchard SB. Could smoking PROTECT against coronavirus? Mail Online. 2020. . Cited February 2, 2021.
    1. Herbec A, Brown J, Jackson S, et al. . Perceived risk factors for severe Covid-19 symptoms and their association with health behaviours: findings from the HEBECO study. PsyArXiv. . Cited February 2, 2021.
    1. Wada K, Smith DR. Influenza vaccination uptake among the working age population of Japan: results from a national cross-sectional survey. PLoS One. 2013;8(3):e59272.
    1. Mangtani P, Breeze E, Kovats S, Ng ES, Roberts JA, Fletcher A. Inequalities in influenza vaccine uptake among people aged over 74 years in Britain. Prev Med. 2005;41(2):545–553.
    1. Lu PJ, Gonzalez-Feliciano A, Ding H, et al. . Influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination among adults 25 to 64 years of age with high-risk conditions – United States, 2010. Am J Infect Control. 2013;41(8):702–709.
    1. Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: implications for public health communications. Lancet Reg Health Eur. doi:10.1016/j.lanepe.2020.100012.
    1. Martin LR, Petrie KJ. Understanding the dimensions of anti-vaccination attitudes: the Vaccination Attitudes Examination (VAX) Scale. Ann Behav Med. 2017;51(5):652–660.
    1. Office for National Statistics. Population estimates. 2018. . Cited April 25, 2020.
    1. Nicholls LAB, Gallant A, Cogan N, Rasmussen S, Young D, Williams L. Older adults’ vaccine hesitancy: psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake. PsyArXiv; 2020. . Cited December 15, 2020.
    1. Hiscock R, Bauld L, Amos A, Fidler JA, Munafò M. Socioeconomic status and smoking: a review. Ann N Y Acad Sci. 2012;1248:107–123.
    1. Patel JA, Nielsen FBH, Badiani AA, et al. . Poverty, inequality and COVID-19: the forgotten vulnerable. Public Health. 2020;183:110–111.
    1. Christakis NA, Fowler JH. The collective dynamics of smoking in a large social network. N Engl J Med. 2008;358(21):2249–2258.
    1. Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.
    1. Freeman D, Loe BS, Chadwick A, et al. . COVID-19 vaccine hesitancy in the UK: the Oxford Coronavirus Explanations, Attitudes, and Narratives Survey (Oceans) II. Psychol Med. 2020;1–15. doi: 10.1017/S0033291720005188.
    1. World Health Organization. Behavioural considerations for acceptance and uptake of COVID-19 vaccines. 2020. (WHO technical advisory group on behavioural insights and sciences for health, meeting report, 15 October 2020). . Cited December 15, 2020.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner